We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sunesis Pharmaceuticals Inc | NASDAQ:SNSS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.32 | 4.72 | 4.75 | 0 | 01:00:00 |
SUNESIS
PHARMACEUTICALS, INC.
|
(Exact
Name of Registrant as Specified in its
Charter)
|
Delaware
|
000-51531
|
94-3295878
|
(State
or Other Jurisdiction
|
(Commission
|
(IRS
Employer
|
of
Incorporation)
|
File
Number)
|
Identification
No.)
|
341
Oyster Point Boulevard
South
San Francisco, California
|
94080
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Not
Applicable
|
(Former
Name or Former Address, if Changed Since Last
Report.)
|
SUNESIS
PHARMACEUTICALS, INC.
|
||
|
|
|
Date:
May 8, 2008
|
By: | /s/ ERIC H. BJERKHOLT |
Eric
H. Bjerkholt
|
||
Senior
Vice President, Corporate Development and Finance and Chief Financial
Officer
|
Exhibit No. |
Description
|
99.1 |
Press
release issued by Sunesis Pharmaceuticals, Inc., dated May 8,
2008.
|
1 Year Sunesis Pharmaceuticals Chart |
1 Month Sunesis Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions